| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |